Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (321-330 of 511) with videos related to

Pageof 52
Sort By:
BMC Infectious Diseases|January 24, 2023
Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIVLeona Dold, Mette J Nielsen, Michael Praktiknjo, et al.
Scientific Reports|August 14, 2019
TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptorSabine Klein, Carola-Ellen Kleine, Andrea Pieper, et al.
The Lancet. Microbe|September 7, 2024
State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensusJulie Rodriguez, Zahra Hassani, Carolina Alves Costa Silva, et al.
Plos One|February 4, 2015
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfectionChristian Jansen, Thomas Reiberger, Jia Huang, et al.
Journal of Hepatology|April 18, 2025
Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensusPaolo Angeli, Christian Labenz, Salvatore Piano, et al.
Journal of Hepatology|December 15, 2010
Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndromeSimone Talens, Jildou Hoekstra, Steffen P G Dirkx, et al.
Cells|October 25, 2024
Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of PhenobarbitalNico Kraus, Frank Erhard Uschner, Magnus Moeslein, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patientsEvrim Anadol, Robert Schierwagen, Natalia Elfimova, et al.
Plos One|July 12, 2019
Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cARTLeona Dold, Mette J Nielsen, Michael Praktiknjo, et al.
Plos One|October 24, 2019
Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosisAlexander Queck, Dominique Thomas, Christian Jansen, et al.
Pageof 52

Showing results (321-330 of 511) with videos related to

Sort By:
Pageof 52
BMC Infectious Diseases|January 24, 2023
Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIVLeona Dold, Mette J Nielsen, Michael Praktiknjo, et al.
Scientific Reports|August 14, 2019
TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptorSabine Klein, Carola-Ellen Kleine, Andrea Pieper, et al.
The Lancet. Microbe|September 7, 2024
State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensusJulie Rodriguez, Zahra Hassani, Carolina Alves Costa Silva, et al.
Plos One|February 4, 2015
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfectionChristian Jansen, Thomas Reiberger, Jia Huang, et al.
Journal of Hepatology|April 18, 2025
Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensusPaolo Angeli, Christian Labenz, Salvatore Piano, et al.
Journal of Hepatology|December 15, 2010
Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndromeSimone Talens, Jildou Hoekstra, Steffen P G Dirkx, et al.
Cells|October 25, 2024
Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of PhenobarbitalNico Kraus, Frank Erhard Uschner, Magnus Moeslein, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patientsEvrim Anadol, Robert Schierwagen, Natalia Elfimova, et al.
Plos One|July 12, 2019
Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cARTLeona Dold, Mette J Nielsen, Michael Praktiknjo, et al.
Plos One|October 24, 2019
Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosisAlexander Queck, Dominique Thomas, Christian Jansen, et al.
Pageof 52